ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Nachawati Law Group Trial Lawyers Renew Commitment to Cancer Victims After Judge’s Rejection of Johnson & Johnson’s Proposed $8.9B Settlement

Trial Lawyers Press on with J&J Litigation, Justice for Cancer Victims

Attorneys representing thousands of cancer victims vowed to press on with litigation against Johnson & Johnson (NYSE: JNJ) after a federal judge rejected for a second time a proposed settlement of claims that J&J’s talc-based products cause cancer.

U.S. Bankruptcy Judge Michael Kaplan rejected the proposed $8.9 billion settlement tied to a bankruptcy filing by J&J subsidiary LTL Management. According to the judge’s ruling, J&J and LTL had not demonstrated that the company is in the kind of financial distress that would warrant bankruptcy.

Trial lawyers with Dallas-based Nachawati Law Group have played a key role in bankruptcy litigation against Johnson & Johnson and helped negotiate the most recent proposed settlement.

“Our firm respects Judge Kaplan’s decision,” said Nachawati Law Group founder Majed Nachawati, who represents more than 5,000 ovarian cancer victims. “We will continue to push for trial on behalf of each and every one of our clients and engage in resolution discussions with Johnson & Johnson with the goal of reaching a fair settlement that will provide much-needed closure to all our clients.”

According to the lawsuits, J&J failed to warn users of its Johnson’s Baby Powder and Shower-to-Shower products about asbestos contamination and other known risks. Internal records produced by the company show that, for generations, the company has known about links between the products and cancer. All the while, the company heavily advertised and marketed its products to women for feminine hygiene use.

Numerous jury trials have resulted in findings that J&J talc products cause cancer. Verdicts, settlements and legal fees now exceed $4.5 billion, according to J&J. Most recently, a California jury returned an $18.8 million verdict on behalf of a man who developed cancer after using Johnson’s Baby Powder.

J&J has been trying to resolve more than 38,000 cancer lawsuits since 2021. Using a controversial bankruptcy strategy, the corporation sought to shed its verdicts and pending legal liabilities in a shell company known as LTL Management, which immediately filed for bankruptcy protection.

Nachawati Law Group represents individuals in mass tort litigation, businesses and governmental entities in contingent litigation, and individual victims in serious personal injury litigation. For more information, visit www.ntrial.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  244.22
+21.36 (9.58%)
AAPL  270.37
-1.03 (-0.38%)
AMD  256.12
+1.28 (0.50%)
BAC  53.45
+0.42 (0.79%)
GOOG  281.82
-0.08 (-0.03%)
META  648.35
-18.12 (-2.72%)
MSFT  517.81
-7.95 (-1.51%)
NVDA  202.49
-0.40 (-0.20%)
ORCL  262.61
+5.72 (2.23%)
TSLA  456.56
+16.46 (3.74%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.